Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF).

Yasser Ged, Chung‐Han Lee, Cihan Düzgöl et al.|Journal of Clinical Oncology|2019

Cited by 5